|
CN108780093A
|
|
Chromogranin A as bladder carcinoma marker
|
|
CN106662590A
|
|
Early placenta insulin-like peptide (pro-EPIL)
|
|
CN106461673A
|
|
Immunoassay and antibodies for the detection of chromogranin A
|
|
CN105917232A
|
|
Method for the selective determination of placental growth factor 2
|
|
WO2013050383A2
|
|
In vitro method to determine the risk of a pregnant woman of carrying a fetus with fetal aneuploidy
|
|
WO2012101268A1
|
|
In vitro method to determine the risk of a pregnant woman of carrying a fetus with fetal aneuploidy
|
|
BR112012032406A2
|
|
markers for prognosis and risk assessment of pregnancy-induced hypertension and preeclampsia
|
|
EP1867995A1
|
|
In vitro method for diagnosing and monitoring metastasized bladder cancer using the determination of MMP-7 in the circulation of patients
|
|
EP1757940A1
|
|
In vitro method for diagnosing and monitoring renal cell carcinoma (RCC) using MMP-7 as humoral biomarker for RCC
|
